Exact Sciences
EXAS
#1718
Rank
A$15.06 B
Marketcap
$81.42
Share price
0.70%
Change (1 day)
-18.01%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.36

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.43. In 2022 the company made an earnings per share (EPS) of -$5.43 a decrease over its 2021 EPS that were of -$5.31.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.36-56.62%
2022-$5.432.31%
2021-$5.31-37.09%
2020-$8.44674.65%
2019-$1.09-50.69%
2018-$2.2144%
2017-$1.53-39.39%
2016-$2.53-2.94%
2015-$2.6137.1%
2014-$1.9079.71%
2013-$1.06-21.59%
2012-$1.3562.96%
2011-$0.8392.86%
2010-$0.43-3.45%
2009-$0.44-19.44%
2008-$0.55-18.18%
2007-$0.68-10.2%
2006-$0.75-10.91%
2005-$0.84-24.66%
2004-$1.12-51.33%
2003-$2.30-7.41%
2002-$2.4911.72%
2001-$2.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.66 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.52-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.61-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$78.10 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.88-300.57%๐Ÿ‡ซ๐Ÿ‡ท France